For laboratory research use only. Not for human or animal consumption.
BioIntegrityResearch

Vitality

Melanotan II

Melanotan-II

Melanotan-II (MT-II)

Research context

Melanotan II is a cyclic lactam analogue of α-melanocyte-stimulating hormone characterised as a non-selective agonist across melanocortin receptor subtypes. Research examines melanogenesis in melanocyte culture and receptor binding across the MC1R–MC5R family.

Common assays: Melanogenesis quantification · MC receptor panel binding · Tyrosinase activity

Specification

DesignationMelanotan-II
Full nameMelanotan-II (MT-II)
SequenceAc-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂
CAS number121062-08-6
Molecular formulaC50H69N15O9
Molecular weight1024.18 g/mol
Formats10 mL Vial · 15 mL Nasal Spray · 15 mL Oral Spray
SolubilitySterile water, bacteriostatic water
StorageLyophilised: −20 °C, protected from light. Reconstituted: 2–8 °C.
Current lotMEL215N0126

Published literature

Selected peer-reviewed references describing research involving this compound. Listed for reference only; inclusion is not a claim about any outcome.

  1. Hadley ME, Dorr RT.Melanocortin peptide therapeutics: historical milestones, clinical studies and commercializationPeptides · 2006 Find on PubMed ↗

Common questions

What distinguishes Melanotan II from PT-141 structurally?

Melanotan II carries a C-terminal amide; PT-141 has a free carboxyl at that position. The difference is associated with the distinct receptor selectivity profiles reported for each.

Same pathway

Related compounds